TRPV4 and central nervous system cancer: Accordingly, TRPV4 blockade, induced by the specific TRPV4 inhibitor HC-067047, was found to decrease motility and invasiveness of U87 glioma cells through a P-AKT and Rac1 signaling pathway (Ou-yang et al., 2018).